Advertisement
Thursday, 30 March 2023
E-paper
Home
Opinion
India
My Kolkata
News
Places
People
Lifestyle
Events
Food
Try This
Edugraph
News
Career
Campus
18 Under 18
Colleges
States
West Bengal
North East
Jharkhand
World
Business
Science & Tech
Health
Sports
Cricket
Football
Horse Racing
Entertainment
Culture
Bob Dylan@80
Heritage
Travel
Style
People
Books
Food
Arts
Music
Gallery
Search
Home
/
Topic
/
Covaxin
Covaxin
Calcutta
/
Published 05.05.21
Vaccine or placebo, unsure at trials
The youths had not sought the information earlier, but now that vaccination has been opened for the 18-44 age group, they need the details...
By Subhajoy Roy in Calcutta
India
/
Published 30.04.21
Covaxin price reduced for states
The price cut followed widespread criticism as Bharat Biotech had sold it to the central government at Rs 150 per dose...
By Our Bureau, PTI in New Delhi
India
/
Published 29.04.21
Covaxin: Rs 400 for states now
Company says it is ‘deeply concerned’ with the critical pandemic circumstances in India...
By Our Bureau, Agencies in Hyderabad
Calcutta
/
Published 27.04.21
Jab leeway with rider
The government now supplies doses to healthcare centres which will end on April 30...
By Subhajoy Roy in Calcutta
India
/
Published 26.04.21
Vaccine: Centre asks for price cut
Both are available at a rate of Rs 150 per dose to the central government...
By PTI in New Delhi
Advertisement
India
/
Published 25.04.21
Covaxin at Rs 1,200, call for Centre funds
It is twice the corresponding price tag on Covishield, the AstraZeneca vaccine produced in the country by the Serum Institute of India...
By G.S. Mudur in New Delhi
India
/
Published 22.04.21
Covid: Few infections after vaccines
Only three to four persons per 10,000 inoculated were affected by the coronavirus after two doses...
By G.S. Mudur in New Delhi
India
/
Published 21.04.21
Over 21k got Covid after taking jabs
More than 5,500 contracted coronavirus after receiving second jab, says Centre...
By Our Bureau, Agencies in New Delhi
India
/
Published 21.04.21
Covaxin shows 78% efficacy in Phase 3
Bharat Biotech vaccine 70 per cent efficient in asymptomatic patients according to interim analysis results...
By Our Bureau, Agencies in Hyderabad
India
/
Published 20.04.21
Rs 4,500 cr advance for vaccine makers
Covaxin production ramped up to 700 million doses per annum...
By Our Bureau, Agencies in Hyderabad, New Delhi
First
«
Previous
19
20
21
22
23
24
25
»
Next
Last
Advertisement
Download our latest App
to get update on the go...
Advertisement
Advertisement
Copyright © 2020 The Telegraph. All rights reserved.
About
|
Contact us
|
Terms of use
|
Privacy Policy